163 related articles for article (PubMed ID: 1658705)
21. Influence of a V kappa 8 L chain transgene on endogenous rearrangements and the immune response to the HA(Sb) determinant on influenza virus.
Carmack CE; Camper SA; Mackle JJ; Gerhard WU; Weigert MG
J Immunol; 1991 Sep; 147(6):2024-33. PubMed ID: 1909739
[TBL] [Abstract][Full Text] [Related]
22. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes.
Benvenisty N; Ornitz DM; Bennett GL; Sahagan BG; Kuo A; Cardiff RD; Leder P
Oncogene; 1992 Dec; 7(12):2399-405. PubMed ID: 1461648
[TBL] [Abstract][Full Text] [Related]
23. IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.
Möröy T; Fisher P; Guidos C; Ma A; Zimmerman K; Tesfaye A; DePinho R; Weissman I; Alt FW
EMBO J; 1990 Nov; 9(11):3659-66. PubMed ID: 2120050
[TBL] [Abstract][Full Text] [Related]
24. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
[TBL] [Abstract][Full Text] [Related]
25. Reticulum cell sarcomas of SJL mice have rearranged immunoglobulin heavy and light chain genes.
Stavnezer J; Lasky JL; Ponzio NM; Scheid MP; Thorbecke GJ
Eur J Immunol; 1989 Jun; 19(6):1063-9. PubMed ID: 2546779
[TBL] [Abstract][Full Text] [Related]
26. Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice.
Vaux DL; Adams JM; Alexander WS; Pike BL
J Immunol; 1987 Dec; 139(11):3854-60. PubMed ID: 2445821
[TBL] [Abstract][Full Text] [Related]
27. Transgenic mice as a means to study synergism between oncogenes.
Berns A; Breuer M; Verbeek S; van Lohuizen M
Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
[TBL] [Abstract][Full Text] [Related]
28. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression.
Dildrop R; Ma A; Zimmerman K; Hsu E; Tesfaye A; DePinho R; Alt FW
EMBO J; 1989 Apr; 8(4):1121-8. PubMed ID: 2501083
[TBL] [Abstract][Full Text] [Related]
29. Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.
Iwamoto T; Pu M; Ito M; Takahashi M; Isobe K; Nagase F; Kawashima K; Ichihara M; Nakashima I
Eur J Immunol; 1991 Aug; 21(8):1809-14. PubMed ID: 1868872
[TBL] [Abstract][Full Text] [Related]
30. Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice.
Möröy T; Grzeschiczek A; Petzold S; Hartmann KU
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10734-8. PubMed ID: 7504280
[TBL] [Abstract][Full Text] [Related]
31. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
Alexander WS; Schrader JW; Adams JM
Mol Cell Biol; 1987 Apr; 7(4):1436-44. PubMed ID: 3037318
[TBL] [Abstract][Full Text] [Related]
32. Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally.
Verbeek S; van Lohuizen M; van der Valk M; Domen J; Kraal G; Berns A
Mol Cell Biol; 1991 Feb; 11(2):1176-9. PubMed ID: 1990273
[TBL] [Abstract][Full Text] [Related]
33. Ectopic expression of myc or myn down-regulates immunoglobulin transcription.
Sigvardsson M; Johansson K; Larsson LG; Nilsson K; Leanderson T
Leukemia; 1994 Jul; 8(7):1157-63. PubMed ID: 8035607
[TBL] [Abstract][Full Text] [Related]
34. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.
Tsatsanis C; Fulton R; Nishigaki K; Tsujimoto H; Levy L; Terry A; Spandidos D; Onions D; Neil JC
J Virol; 1994 Dec; 68(12):8296-303. PubMed ID: 7966623
[TBL] [Abstract][Full Text] [Related]
35. Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2.
van der Lugt NM; Domen J; Verhoeven E; Linders K; van der Gulden H; Allen J; Berns A
EMBO J; 1995 Jun; 14(11):2536-44. PubMed ID: 7781606
[TBL] [Abstract][Full Text] [Related]
36. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.
Rosenbaum H; Webb E; Adams JM; Cory S; Harris AW
EMBO J; 1989 Mar; 8(3):749-55. PubMed ID: 2785918
[TBL] [Abstract][Full Text] [Related]
37. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.
Langdon WY; Harris AW; Cory S; Adams JM
Cell; 1986 Oct; 47(1):11-8. PubMed ID: 3093082
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of endogenous myc gene down-regulation in E mu-N-myc tumors.
Ma A; Smith RK; Tesfaye A; Achacoso P; Dildrop R; Rosenberg N; Alt FW
Mol Cell Biol; 1991 Jan; 11(1):440-4. PubMed ID: 1986238
[TBL] [Abstract][Full Text] [Related]
39. Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.
Yukawa K; Kikutani H; Inomoto T; Uehira M; Bin SH; Akagi K; Yamamura K; Kishimoto T
J Exp Med; 1989 Sep; 170(3):711-26. PubMed ID: 2504875
[TBL] [Abstract][Full Text] [Related]
40. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.
van Lohuizen M; Verbeek S; Scheijen B; Wientjens E; van der Gulden H; Berns A
Cell; 1991 May; 65(5):737-52. PubMed ID: 1904008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
